Myocardial extracellular volume measurement using cardiac computed tomography.

Cardiomyopathies Fibrosis Multidetector Computed Tomography Myocardium

Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 09 04 2024
accepted: 13 08 2024
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Myocardial fibrosis is a common endpoint of many cardiac diseases and increasingly recognized as a predictor of heart failure, arrhythmia, and death. Recent studies have utilised cardiac computed tomography (CT) scans with delayed phase imaging to quantify diffuse fibrosis of the myocardium. CT extracellular volume (CT-ECV) measurement correlates well with CMR and histological myocardial fibrosis. Furthermore, CT-ECV predicts outcomes such as death, heart failure and arrhythmia in various disease states. This review summarizes the rationale and methodology behind CT-ECV measurement and provides a detailed summary of the current clinical evidence for the use of CT-ECV.

Identifiants

pubmed: 39400790
doi: 10.1007/s10554-024-03226-4
pii: 10.1007/s10554-024-03226-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO et al (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56(4):278–287
doi: 10.1016/j.jacc.2009.12.074 pubmed: 20633819
Díez J (2007) Mechanisms of Cardiac Fibrosis in Hypertension. J Clin Hypertens (Greenwich) 9(7):546–550
doi: 10.1111/j.1524-6175.2007.06626.x pubmed: 17617765
Scully PR, Patel KP, Saberwal B, Klotz E, Augusto JB, Thornton GD et al (2020) Identifying Cardiac amyloid in aortic stenosis: ECV quantification by CT in TAVR patients. JACC: Cardiovasc Imaging 13(10):2177–2189
pubmed: 32771574
Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH (1995) Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 91(1):161–170
doi: 10.1161/01.CIR.91.1.161 pubmed: 7805198
Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436–1441
doi: 10.1136/heartjnl-2012-302346 pubmed: 22936681
Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 mapping in characterizing myocardial disease. Circul Res 119(2):277–299
doi: 10.1161/CIRCRESAHA.116.307974
Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A et al (2012) Interstitial myocardial fibrosis assessed as extracellular volume fraction with Low-Radiation-Dose Cardiac CT. Radiology 264(3):876–883
doi: 10.1148/radiol.12112458 pubmed: 22771879 pmcid: 3426854
Bandula S, White SK, Flett AS, Lawrence D, Pugliese F, Ashworth MT et al (2013) Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. Radiology 269(2):396–403
doi: 10.1148/radiol.13130130 pubmed: 23878282
Han D, Lin A, Kuronuma K, Gransar H, Dey D, Friedman JD et al (2023) Cardiac Computed Tomography for quantification of myocardial extracellular volume fraction: a systematic review and Meta-analysis. JACC Cardiovasc Imaging 16(10):1306–1317
doi: 10.1016/j.jcmg.2023.03.021 pubmed: 37269267
Koike H, Cheng VY, Lesser A, Enriquez-Sarano M, Caye DJ, Aluru JS et al Importance of imaging-acquisition protocol and post-processing analysis for extracellular volume fraction assessment by computed tomography. Journal of Cardiovascular Computed Tomography [Internet]. 2023 Mar 13 [cited 2023 May 16]; https://www.sciencedirect.com/science/article/pii/S1934592523000825
Treibel TA, Bandula S, Fontana M, White SK, Gilbertson JA, Herrey AS et al (2015) Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9(6):585–592
doi: 10.1016/j.jcct.2015.07.001 pubmed: 26209459 pmcid: 4684159
Funama Y, Oda S, Kidoh M, Sakabe D, Nakaura T (2022) Effect of image quality on myocardial extracellular volume quantification using cardiac computed tomography: a phantom study. Acta Radiol 63(2):159–165
doi: 10.1177/0284185120986938 pubmed: 33461303
Palmisano A, Vignale D, Tadic M, Moroni F, De Stefano D, Gatti M et al (2022) Myocardial late contrast enhancement CT in troponin-positive acute chest Pain Syndrome. Radiology 302(3):545–553
doi: 10.1148/radiol.211288 pubmed: 34874200
Suzuki M, Toba T, Izawa Y, Fujita H, Miwa K, Takahashi Y et al (2021) Prognostic impact of myocardial extracellular volume Fraction Assessment using dual-energy computed tomography in patients treated with aortic valve replacement for severe aortic stenosis. J Am Heart Association 10(18):e020655
doi: 10.1161/JAHA.120.020655
Gama F, Rosmini S, Bandula S, Patel KP, Massa P et al (2022) Tobon -Gomez Catalina,. Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 15(12):2082–94
Abadia AF, van Assen M, Martin SS, Vingiani V, Griffith LP, Giovagnoli DA et al (2020) Myocardial extracellular volume fraction to differentiate healthy from cardiomyopathic myocardium using dual-source dual-energy CT. J Cardiovasc Comput Tomogr 14(2):162–167
doi: 10.1016/j.jcct.2019.09.008 pubmed: 31615736
Tamarappoo B, Han D, Tyler J, Chakravarty T, Otaki Y, Miller R et al (2020) Prognostic Value of Computed Tomography–Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis. JACC: Cardiovascular Imaging. 13(12):2591–601
Arakawa H, Tomizawa N, Chou S, Matsuoka S, Yamamoto K, Inoh S et al (2020) Low iodine dose is related with overestimation of extracellular volume derived from cardiac ct. Cardi Imag Asia 4(2):38–44.
Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C et al (2016) Effectiveness of Prevention strategies for contrast-Induced Nephropathy. Ann Intern Med 164(6):406–416
doi: 10.7326/M15-1456 pubmed: 26830221
Hamdy A, Kitagawa K, Goto Y, Yamada A, Nakamura S, Takafuji M et al (2019) Comparison of the different imaging time points in delayed phase cardiac CT for myocardial scar assessment and extracellular volume fraction estimation in patients with old myocardial infarction. Int J Cardiovasc Imaging 35(5):917–926
doi: 10.1007/s10554-018-1513-z pubmed: 30564976
Jablonowski R, Wilson MW, Do L, Hetts SW, Saeed M (2015) Multidetector CT Measurement of Myocardial Extracellular volume in Acute patchy and contiguous infarction: validation with microscopic measurement. Radiology 274(2):370–378
doi: 10.1148/radiol.14140131 pubmed: 25247406
Lee HJ, Im DJ, Youn JC, Chang S, Suh YJ, Hong YJ et al (2016) Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with Cardiac MR Imaging. Radiology 280(1):49–57
doi: 10.1148/radiol.2016151289 pubmed: 27322972
Hayashi H, Oda S, Emoto T, Kidoh M, Nagayama Y, Nakaura T et al Myocardial extracellular volume quantification by cardiac CT in pulmonary hypertension: Comparison with cardiac MRI. European Journal of Radiology [Internet]. 2022 Aug 1 [cited 2023 May 23];153. https://www.ejradiology.com/article/S0720-048X(22)00236-4/fulltext
Ohta Y, Kitao S, Yunaga H, Fujii S, Mukai N, Yamamoto K et al (2018) Myocardial delayed enhancement CT for the evaluation of Heart failure: comparison to MRI. Radiology 288(3):682–691
doi: 10.1148/radiol.2018172523 pubmed: 29989514
Thirup P (2003) Haematocrit: within-subject and seasonal variation. Sports Med 33(3):231–243
doi: 10.2165/00007256-200333030-00005 pubmed: 12656642
Treibel TA, Fontana M, Steeden JA, Nasis A, Yeung J, White SK et al (2017) Automatic quantification of the myocardial extracellular volume by cardiac computed tomography: synthetic ECV by CCT. J Cardiovasc Comput Tomogr 11(3):221–226
doi: 10.1016/j.jcct.2017.02.006 pubmed: 28268091
González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-del Moral FJ, Cobo-Marcos M, Robles C et al (2015) Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2585–2594
doi: 10.1093/eurheartj/ehv338 pubmed: 26224076
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis Treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007–1016
doi: 10.1056/NEJMoa1805689 pubmed: 30145929
Kidoh M, Oda S, Takashio S, Hirakawa K, Kawano Y, Shiraishi S et al (2023) CT extracellular volume fraction versus myocardium-to-Lumen Signal ratio for Cardiac Amyloidosis. Radiology 306(3):e220542
doi: 10.1148/radiol.220542 pubmed: 36255307
Hein S, Arnon E, Kostin S, Schönburg M, Elsässer A, Polyakova V et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded Human Heart. Circulation 107(7):984–991
doi: 10.1161/01.CIR.0000051865.66123.B7 pubmed: 12600911
Malhotra P, Han D, Chakravarty T, Thomson L, Dey D, Nakamura M et al (2024) Increased CT angiography-derived extracellular volume fraction predicts less benefit in left ventricular remodeling and ejection fraction after transcatheter edge to edge repair for severe mitral regurgitation. Journal of Cardiovascular Computed Tomography [Internet]. Feb 1 [cited 2024 Feb 12]; https://www.sciencedirect.com/science/article/pii/S1934592524000133
Monti CB, Zanardo M, Bosetti T, Alì M, Benedictis ED, Luporini A et al (2020) Assessment of myocardial extracellular volume on body computed tomography in breast cancer patients treated with anthracyclines. Quant Imaging Med Surg 10(5):93444–93944
doi: 10.21037/qims.2020.04.05
Capra D, Monti CB, Luporini AG, Lombardi F, Gumina C, Sironi A et al (2020) Computed tomography-derived myocardial extracellular volume: an early biomarker of cardiotoxicity in esophageal cancer patients undergoing radiation therapy. Insights into Imaging 11(1):120
doi: 10.1186/s13244-020-00922-2 pubmed: 33226481 pmcid: 7683763

Auteurs

Rahul G Muthalaly (RG)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.

Timothy Abrahams (T)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.

Andrew Lin (A)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.
St. Bartholomew's Heart Centre, London, UK.

Kush Patel (K)

St. Bartholomew's Heart Centre, London, UK.

Sean Tan (S)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.

Damini Dey (D)

Department of Biomedical Sciences, Biomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.

Donghee Han (D)

Department of Biomedical Sciences, Biomedical Imaging Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.

Balaji K Tamarappoo (BK)

Cardiovascular Institute, Indiana University School of Medicine, Indianapolis, IN, USA.

Stephen J Nicholls (SJ)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia.

Nitesh Nerlekar (N)

Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. Nitesh.nerlekar@monash.edu.
Victorian Heart Hospital, Monash Health, Clayton, VIC, Australia. Nitesh.nerlekar@monash.edu.
Baker Heart and Diabetes Institute, Commercial Road, Melbourne, 3004, Australia. Nitesh.nerlekar@monash.edu.

Classifications MeSH